{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:00:44Z","timestamp":1777417244399,"version":"3.51.4"},"reference-count":93,"publisher":"Medknow","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":294,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Saudi Journal of Ophthalmology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.sjopt.2012.07.006","type":"journal-article","created":{"date-parts":[[2012,8,17]],"date-time":"2012-08-17T03:00:49Z","timestamp":1345172449000},"page":"385-392","source":"Crossref","is-referenced-by-count":20,"title":["Update on advanced imaging options for thyroid-associated orbitopathy"],"prefix":"10.4103","volume":"26","author":[{"given":"Michael P.","family":"Rabinowitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline R.","family":"Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2581","reference":[{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.survophthal.2009.06.009","article-title":"Immunopathogenesis of thyroid eye disease: emerging paradigms","volume":"55","author":"Naik","year":"2010","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2009-1614","article-title":"Increased generation of fibrocytes in thyroid-associated ophthalmopathy","volume":"95","author":"Douglas","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0015","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2010-1424","article-title":"Regulatory T-cells in Graves\u2019 orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin","volume":"96","author":"Kahaly","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.sjopt.2012.07.006_b0020","first-page":"1547","article-title":"Orbital scintigraphy with the somatostatin receptor tracer 99mTc-P829 in patients with Graves\u2019 disease","volume":"44","author":"Burggasser","year":"2003","journal-title":"J Nucl Med"},{"issue":"6","key":"10.1016\/j.sjopt.2012.07.006_b0025","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1152\/ajpcell.1999.277.6.C1075","article-title":"Leukoregulin upregulation of prostaglandin endoperoxide H synthase-2 expression in human orbital fibroblasts","volume":"277","author":"Cao","year":"1999","journal-title":"Am J Physiol"},{"issue":"19","key":"10.1016\/j.sjopt.2012.07.006_b0030","doi-asserted-by":"crossref","first-page":"16355","DOI":"10.1074\/jbc.M111246200","article-title":"Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression","volume":"277","author":"Han","year":"2002","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.sjopt.2012.07.006_b0035","first-page":"4079","article-title":"Expression of hyaluronan synthase messenger ribonucleic acids and their induction by Interleukin-1{beta} in human orbital fibroblasts: potential insight into the molecular pathogenesis of thyroid-associated ophthalmopathy","volume":"84","author":"Kaback","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0040","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1167\/iovs.10-5276","article-title":"Altered ganglioside expression modulates the pathogenic mechanism of thyroid-associated ophthalmopathy by increase in hyaluronic acid","volume":"52","author":"Kook","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.sjopt.2012.07.006_b0045","first-page":"417","article-title":"Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?","volume":"4","author":"Lahooti","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"10.1016\/j.sjopt.2012.07.006_b0050","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves\u2019 disease","volume":"181","author":"Tsui","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0055","first-page":"222","article-title":"Pathogenesis of thyroid eye disease-does autoimmunity against the TSH receptor explain all cases?","volume":"61","author":"Wall","year":"2010","journal-title":"Endokrynol Pol"},{"issue":"4","key":"10.1016\/j.sjopt.2012.07.006_b0060","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/01676830903104629","article-title":"Can autoimmunity against calsequestrin explain the eye and eyelid muscle inflammation of thyroid eye disease?","volume":"28","author":"Gopinath","year":"2009","journal-title":"Orbit"},{"issue":"20","key":"10.1016\/j.sjopt.2012.07.006_b0470","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199311113292007","article-title":"Pathogenesis of Graves\u2019 ophthalmopathy","volume":"329","author":"Bahn","year":"1993","journal-title":"New Engl J Med"},{"issue":"6","key":"10.1016\/j.sjopt.2012.07.006_b0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ajo.2006.02.047","article-title":"Pathogenesis of graves ophthalmopathy: implications for prediction, prevention, and treatment","volume":"142","author":"Garrity","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.sjopt.2012.07.006_b0080","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/105072502761016476","article-title":"Epidemiology and prevention of Graves\u2019 ophthalmopathy","volume":"12","author":"Wiersinga","year":"2002","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.sjopt.2012.07.006_b0085","first-page":"747","article-title":"Graves\u2019 ophthalmopathy: current concepts regarding pathogenesis and management","volume":"14","author":"Burch","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/j.sjopt.2012.07.006_b0090","series-title":"Williams textbook of endocrinology","first-page":"374","article-title":"Thyrotoxicosis","author":"Larsen","year":"2003"},{"key":"10.1016\/j.sjopt.2012.07.006_b0095","first-page":"477","article-title":"The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota","volume":"92","author":"Bartley","year":"1994","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1210\/jc.2010-2329","article-title":"The dilemma of how to manage Graves\u2019 hyperthyroidism in patients with associated orbitopathy","volume":"96","author":"Bartalena","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.sjopt.2012.07.006_b0105","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMcp0806317","article-title":"Clinical practice-Graves\u2019 ophthalmopathy","volume":"360","author":"Bartalena","year":"2009","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0110","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/0974-9233.63079","article-title":"Graves opthalmopathy and psychoendocrinopathies","volume":"17","author":"Ghanemm","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"5","key":"10.1016\/j.sjopt.2012.07.006_b0115","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1530\/EJE-11-0055","article-title":"Quality of life in thyroid eye disease: impact of quality of care","volume":"164","author":"Estcourt","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.sjopt.2012.07.006_b0120","first-page":"368","article-title":"Quality of life in patients with Graves ophthalmopathy","volume":"103","author":"Yeatts","year":"2005","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"7","key":"10.1016\/j.sjopt.2012.07.006_b0125","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1210\/jcem-29-7-982","article-title":"Classification of the eye changes of Graves\u2019 disease","volume":"29","author":"Werner","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.sjopt.2012.07.006_b0130","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0002-9394(77)90140-4","article-title":"Modification of the classification of the eye changes of Graves\u2019 disease","volume":"83","author":"Werner","year":"1977","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.sjopt.2012.07.006_b0135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves\u2019 ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves\u2019 ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"10.1016\/j.sjopt.2012.07.006_b0145","first-page":"302","article-title":"Optimal management of Graves orbitopathy: a multidisciplinary approach","volume":"69","author":"Soeters","year":"2011","journal-title":"Neth J Med"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"European Group on Graves\u2019 Orbitopathy (EUGOGO). Consensus statement of the European Group on Graves\u2019 orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.sjopt.2012.07.006_b0155","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ncpendmet0497","article-title":"Management of Graves\u2019 ophthalmopathy","volume":"3","author":"Wiersinga","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2265.1998.00487.x","article-title":"Current management of thyroid-associated ophthalmopathy in Europe. Results of an international survey","volume":"49","author":"Weetman","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.0.1450107","article-title":"Imaging in thyroid-associated orbitopathy","volume":"145","author":"Kahaly","year":"2001","journal-title":"Eur J Endocrinol"},{"issue":"43\u201344","key":"10.1016\/j.sjopt.2012.07.006_b0170","first-page":"618","article-title":"Graves\u2019 orbitopathy: current imaging procedures","volume":"139","author":"Kirsch","year":"2009","journal-title":"Swiss Med Wkly"},{"issue":"5\u20136","key":"10.1016\/j.sjopt.2012.07.006_b0175","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF00344110","article-title":"Standardized echography of the eye and orbit","volume":"28","author":"Byrne","year":"1986","journal-title":"Neuroradiology"},{"key":"10.1016\/j.sjopt.2012.07.006_b0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1755-3768.1992.tb04932.x","article-title":"The role of standardized echography in Graves\u2019 disease","volume":"204","author":"Ossoinig","year":"1992","journal-title":"Acta Ophthalmol Suppl"},{"key":"10.1016\/j.sjopt.2012.07.006_b0185","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1755-3768.1992.tb04933.x","article-title":"Orbital tumours-the importance of standardized echography","volume":"204","author":"Hasenfratz","year":"1992","journal-title":"Acta Ophthalmol Suppl"},{"issue":"26","key":"10.1016\/j.sjopt.2012.07.006_b0190","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM197406272902602","article-title":"Ultrasonographic evidence of a consistent orbital involvement in Graves\u2019 disease","volume":"290","author":"Werner","year":"1974","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0195","first-page":"171","article-title":"Ultrasonic B-scan measurement of the extraocular muscles in Graves\u2019 orbitopathy","volume":"35","author":"Willinsky","year":"1984","journal-title":"J Can Assoc Radiol"},{"issue":"7","key":"10.1016\/j.sjopt.2012.07.006_b0200","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/medicina46070068","article-title":"Ultrasonic measurement of ocular rectus muscle thickness in patients with Graves\u2019 ophthalmopathy","volume":"46","author":"Imbrasien\u0117","year":"2010","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0205","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1507\/endocrj1954.26.255","article-title":"A quantitative analysis of orbital soft tissue in Graves\u2019 disease based on B-mode ultrasonography","volume":"26","author":"Yamamoto","year":"1979","journal-title":"Endocrinol Jpn"},{"issue":"4","key":"10.1016\/j.sjopt.2012.07.006_b0210","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0161-6420(93)31607-6","article-title":"A new ultrasonographic method to detect disease activity and predict response to immunosuppressive treatment in Graves\u2019 ophthalmopathy","volume":"100","author":"Prummel","year":"1993","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01268094","article-title":"B-scan ultrasonography in Graves\u2019 orbitopathy","volume":"85","author":"Delint","year":"1993","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/j.sjopt.2012.07.006_b0220","first-page":"59","article-title":"Assessment of disease activity of Graves\u2019 ophthalmopathy","volume":"vol. 1(4)","author":"Prummel","year":"2000"},{"issue":"5","key":"10.1016\/j.sjopt.2012.07.006_b0225","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2265.2000.00973.x","article-title":"Assessment of disease activity in Graves\u2019 ophthalmopathy by orbital ultrasonography and clinical parameters","volume":"52","author":"Gerding","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"740","key":"10.1016\/j.sjopt.2012.07.006_b0230","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1259\/0007-1285-62-740-705","article-title":"The use of real\/time orbital ultrasound in Graves\u2019 ophthalmopathy: a comparison with computer tomography","volume":"62","author":"Given-Wilson","year":"1989","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0235","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0360-3016(94)00364-Q","article-title":"Echographic monitoring of response of extraocular muscles to irradiation in Graves\u2019 ophthalmopathy","volume":"31","author":"Erickson","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.sjopt.2012.07.006_b0240","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0161-6420(85)33858-7","article-title":"Extraocular muscle size comparison using standardized A-scan echography and computerized tomography scan measurements","volume":"92","author":"Holt","year":"1985","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.sjopt.2012.07.006_b0245","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/bjo.84.9.1027","article-title":"Colour Doppler imaging of the orbital vasculature in Graves\u2019 disease with computed tomographic correlation","volume":"84","author":"Alp","year":"2000","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.sjopt.2012.07.006_b0250","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jcu.20154","article-title":"Graves\u2019 ophthalmopathy: comparison of the Doppler sonography parameters with the clinical activity score","volume":"33","author":"Yanik","year":"2005","journal-title":"J Clin Ultrasound"},{"issue":"8","key":"10.1016\/j.sjopt.2012.07.006_b0255","first-page":"1329","article-title":"Color Doppler imaging of the superior ophthalmic vein in patients with Graves\u2019 orbitopathy before and after treatment of congestive disease","volume":"66","author":"Monteiro","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0260","first-page":"80","article-title":"Color Doppler imaging of orbital venous flow in dysthyroid optic neuropathy","volume":"38","author":"Nakase","year":"1994","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archopht.1980.01020030273005","article-title":"Ultrasound in early thyroid orbitopathy","volume":"98","author":"Shammas","year":"1980","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0270","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/radiology.177.3.2243967","article-title":"Graves orbitopathy: correlation of CT and clinical findings","volume":"177","author":"Nugent","year":"1990","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.sjopt.2012.07.006_b0275","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1530\/eje.0.1420591","article-title":"Graves\u2019 ophthalmopathy: eye muscle involvement in patients with diplopia","volume":"142","author":"Nagy","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0280","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0002-9394(14)72960-5","article-title":"Comparison of standardized echography with magnetic resonance imaging to measure extraocular muscle size","volume":"118","author":"Demer","year":"1994","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0285","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1590\/S0004-27302011000300002","article-title":"Ultrasonography compared to magnetic resonance imaging in thyroid-associated Graves\u2019 ophthalmopathy","volume":"55","author":"Vlainich","year":"2001","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.sjopt.2012.07.006_b0290","series-title":"Orbital disease, imaging and analysis","author":"Casper","year":"1993"},{"key":"10.1016\/j.sjopt.2012.07.006_b0295","series-title":"Computerized tomography in orbital diseases and neuroopthalmology","first-page":"97","article-title":"Graves\u2019 orbitopathy","author":"Peyster","year":"1984"},{"key":"10.1016\/j.sjopt.2012.07.006_b0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1055\/s-0029-1212180","article-title":"Neuroradiological diagnosis of thyroid-associated orbitopathy","volume":"107","author":"Mu\u00c8ller-Forell","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"6","key":"10.1016\/j.sjopt.2012.07.006_b0305","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0161-6420(81)34993-8","article-title":"Correlation of CT scanning and pathologic features of ophthalmic Graves\u2019 disease","volume":"88","author":"Trokel","year":"1981","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0310","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1148\/118.3.615","article-title":"Computed tomography in Graves\u2019 ophthalmopathy","volume":"118","author":"Enzmann","year":"1976","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.sjopt.2012.07.006_b0315","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00004728-197903060-00019","article-title":"Appearance of Graves\u2019 disease on orbital computed tomography","volume":"3","author":"Enzmann","year":"1979","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0320","first-page":"175","article-title":"Role of rectus muscle enlargement in clinical profile of dysthyroid ophthalmopathy","volume":"35","author":"Yoshikawa","year":"1991","journal-title":"Jpn J Ophthalmol"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0325","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1148\/radiology.167.2.3357962","article-title":"Optic nerve dysfunction in thyroid eye disease: CT","volume":"167","author":"Barrett","year":"1988","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.sjopt.2012.07.006_b0330","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archopht.1982.01030040244006","article-title":"Clinical significance of extraocular muscle volumes in Graves\u2019 ophthalmopathy: a quantitative computed tomography study","volume":"100","author":"Feldon","year":"1982","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0335","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archopht.1985.01050020065021","article-title":"Quantitative computed tomography of Graves\u2019 ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy","volume":"103","author":"Feldon","year":"1985","journal-title":"Arch Ophthalmol"},{"issue":"9","key":"10.1016\/j.sjopt.2012.07.006_b0340","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/bjo.72.9.674","article-title":"Graves\u2019 ophthalmopathy: I. Simple CT estimates of extraocular muscle volume","volume":"72","author":"Hallin","year":"1988","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.sjopt.2012.07.006_b0345","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/bjo.72.9.678","article-title":"Graves\u2019 ophthalmopathy: II. Correlation of clinical signs with measures derived from computed tomography","volume":"72","author":"Hallin","year":"1988","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0350","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002341-200205000-00005","article-title":"CT scan evidence of dysthyroid optic neuropathy","volume":"18","author":"Giaconi","year":"2002","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0355","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1590\/S1807-59322008000300003","article-title":"Diagnostic ability of Barrett\u2019s index to detect dysthyroid optic neuropathy using multidetector computed tomography","volume":"63","author":"Monteiro","year":"2008","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0360","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiology.200.1.8657899","article-title":"Graves ophthalmopathy: intracranial fat prolapse on CT images as an indicator of optic nerve compression","volume":"200","author":"Birchall","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.sjopt.2012.07.006_b0365","series-title":"Radiology of the orbit and visual pathways","author":"Dutton","year":"2010"},{"issue":"894","key":"10.1016\/j.sjopt.2012.07.006_b0370","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1259\/bjr.75.894.750514","article-title":"Can contrast enhanced MRI predict the response ofGraves\u2019 ophthalmopathy to orbital radiotherapy?","volume":"75","author":"Ott","year":"2002","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0375","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1258\/ar.2011.110431","article-title":"Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves\u2019 ophthalmopathy for assessment of disease activity","volume":"53","author":"Jiang","year":"2012","journal-title":"Acta Radiol"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0380","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1148\/radiology.172.3.2772184","article-title":"Graves\u2019 ophthalmopathy: MR imaging of the orbits","volume":"172","author":"Hosten","year":"1989","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0385","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1148\/radiology.179.1.2006276","article-title":"Graves\u2019 ophthalmopathy: role of MR imaging in radiation therapy","volume":"179","author":"Just","year":"1991","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.sjopt.2012.07.006_b0390","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/thy.1992.2.299","article-title":"Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy","volume":"2","author":"Hiromatsu","year":"1992","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0395","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/thy.1995.5.185","article-title":"MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves\u2019 ophthalmopathy","volume":"5","author":"Utech","year":"1995","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0400","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/acta.0.1290213","article-title":"Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid stimulating antibody in patients with Graves\u2019 ophthalmopathy","volume":"129","author":"Nishikawa","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"4","key":"10.1016\/j.sjopt.2012.07.006_b0405","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1167\/iovs.03-1246","article-title":"Demonstration of systematic variation in human intraorbital optic nerve size by quantitative magnetic resonance imaging and histology","volume":"45","author":"Karim","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.sjopt.2012.07.006_b0410","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0161-6420(97)30085-2","article-title":"Subarachnoid fluid of the optic nerve in normal adults","volume":"104","author":"Lam","year":"1997","journal-title":"Ophthalmology"},{"issue":"979","key":"10.1016\/j.sjopt.2012.07.006_b0415","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1259\/bjr\/56958444","article-title":"Use of high-resolution MRI of the optic nerve in Graves\u2019 ophthalmopathy","volume":"82","author":"Dodds","year":"2009","journal-title":"Br J Radiol"},{"issue":"4","key":"10.1016\/j.sjopt.2012.07.006_b0420","first-page":"550","article-title":"Indium-111-pentetreotide scintigraphy in Graves\u2019 ophthalmopathy","volume":"36","author":"Kahaly","year":"1995","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.sjopt.2012.07.006_b0425","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1089\/thy.1995.5.107","article-title":"Role of octreoscan and correlation with MR imaging in Graves\u2019 ophthalmopathy","volume":"5","author":"Kahaly","year":"1995","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.sjopt.2012.07.006_b0430","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/thy.1999.9.47","article-title":"Somatostatin receptor scintigraphy before and after treatment with somatostatin analogues in patients with thyroid eye disease","volume":"9","author":"Krassas","year":"1999","journal-title":"Thyroid"},{"issue":"11","key":"10.1016\/j.sjopt.2012.07.006_b0435","first-page":"3790","article-title":"Orbital scintigraphy with 111In-diethylenetriamine pentaacetic acid-d-phe1-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves\u2019 ophthalmopathy","volume":"83","author":"Colao","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.sjopt.2012.07.006_b0440","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1210\/jcem.79.6.7989493","article-title":"111In-DTPA-D-Phe1 octreotide scintigraphy in thyroidal and orbital Graves\u2019 disease: a parameter for disease activity?","volume":"79","author":"Postema","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0445","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2265.1999.00681.x","article-title":"Octreotide-scintigraphy is a disease-activity parameter in Graves\u2019 ophthalmopathy","volume":"50","author":"Gerding","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"10.1016\/j.sjopt.2012.07.006_b0450","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/eje.0.1400373","article-title":"The role of octreoscan in thyroid eye disease","volume":"140","author":"Krassas","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"10.1016\/j.sjopt.2012.07.006_b0455","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/105072502753600188","article-title":"Octreoscan in thyroid-associated ophthalmopathy","volume":"12","author":"Krassas","year":"2002","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.sjopt.2012.07.006_b0460","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2265.1995.tb02682.x","article-title":"Somatostatin receptor scintigraphy and octreotide treatment in patients with thyroid eye disease","volume":"42","author":"Krassas GEDumas","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.sjopt.2012.07.006_b0465","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1530\/eje.0.1360416","article-title":"Lanreotide in the treatment of patients with thyroid eye disease","volume":"136","author":"Krassas","year":"1997","journal-title":"Eur J Endocrinol"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319453412001063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319453412001063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T13:19:30Z","timestamp":1714310370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319453412001063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1319453412001063"],"URL":"https:\/\/doi.org\/10.1016\/j.sjopt.2012.07.006","relation":{},"ISSN":["1319-4534"],"issn-type":[{"value":"1319-4534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}